Form 8-K - Current report:
SEC Accession No. 0001787306-25-000058
Filing Date
2025-04-10
Accepted
2025-04-10 17:15:02
Documents
16
Period of Report
2025-04-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arqt-20250410.htm   iXBRL 8-K 35934
2 EX-10.1 exhibit101severancechangei.htm EX-10.1 87178
3 EX-99.1 exhibit991pressrelease.htm EX-99.1 19047
7 a1a82.jpg GRAPHIC 25530
  Complete submission text file 0001787306-25-000058.txt   328928

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arqt-20250410.xsd EX-101.SCH 1770
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arqt-20250410_lab.xml EX-101.LAB 22804
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arqt-20250410_pre.xml EX-101.PRE 13038
18 EXTRACTED XBRL INSTANCE DOCUMENT arqt-20250410_htm.xml XML 2864
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

EIN.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39186 | Film No.: 25829227
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)